ALNY

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Alnylam Pharmaceuticals (ALNY) Earnings Date & Reports

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ALNY is expected to report earnings to fall 1,645.67% to -92 cents per share on May 01

Alnylam Pharmaceuticals ALNY Stock Earnings Reports

Q1'25

Est.

$-0.93

Q4'24

Beat

by $0.64

Q3'24

Beat

by $0.43

Q2'24

Beat

by $1.61

Q1'24

Beat

by $0.98

The last earnings report on February 13 showed earnings per share of 5 cents, beating the estimate of -57 cents. With 369.96K shares outstanding, the current market capitalization sits at 29.07B.

View a ticker or compare two or three

Compare

Earnings Traders Earnings Traders

Annualized Return+24%

VIEW DETAILS VIEW DETAILS

SUBSCRIBE SUBSCRIBE

ALNY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ALNY
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ALNY (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

675 West Kendall Street

Phone

+1 617 551-8200

Employees

2100

Web

https://www.alnylam.com